Patent ID: 8574850
Filing Date: 2013-11-05
Classification: A61K,A61P,G01N,Y02A

Abstract:
1. A method for identifying and reducing the risk of an individual for developing sepsis or for developing a gastrointestinal infectious disorder or gastrointestinal inflammatory disorder, the method comprising: (a) measuring the level of at least one antigen in a biological sample from the individual, the at least one antigen being H-1, H-2, Lewis (b) comparing the measured level of the at least one antigen to a predetermined value or a predetermined range of values, (c) identifying the individual as being at risk for developing sepsis or for developing a gastrointestinal infectious disorder or gastrointestinal inflammatory disorder if the measured level of the at least one antigen differs from the predetermined value or is outside the predetermined range of values, and (d) administering to the individual one or more of α1,2 fucosyl glycans, probiotic organisms, or prebiotics, if the individual is identified as being at risk for developing sepsis or for developing a gastrointestinal infectious disorder or gastrointestinal inflammatory disorder.